Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PIM3 antibody (AA 1-326)

The Rabbit Polyclonal anti-PIM3 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect PIM3 in samples from Human.
Catalog No. ABIN7624703

Quick Overview for PIM3 antibody (AA 1-326) (ABIN7624703)

Target

See all PIM3 Antibodies
PIM3 (Pim-3 Oncogene (PIM3))

Reactivity

  • 31
  • 12
  • 2
Human

Host

  • 28
  • 3
Rabbit

Clonality

  • 28
  • 3
Polyclonal

Conjugate

  • 15
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PIM3 antibody is un-conjugated

Application

  • 19
  • 16
  • 16
  • 4
  • 3
  • 2
  • 2
  • 2
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
  • Binding Specificity

    • 9
    • 7
    • 2
    • 1
    • 1
    • 1
    AA 1-326

    Purpose

    Pim-3 Oncogene (PIM3) Polyclonal Antibody

    Sequence

    Met1~Leu326

    Characteristics

    The Pim-3 Oncogene (PIM3) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.

    Purification

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    0.01M PBS,  pH 7.4, containing 0.05 %  Proclin-300, 50 % glycerol

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    PIM3 (Pim-3 Oncogene (PIM3))

    Alternative Name

    PIM3

    Gene ID

    415116

    UniProt

    Q86V86

    Pathways

    Negative Regulation of Hormone Secretion
You are here:
Chat with us!